330 related articles for article (PubMed ID: 23509156)
1. Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity.
Reiners KS; Topolar D; Henke A; Simhadri VR; Kessler J; Sauer M; Bessler M; Hansen HP; Tawadros S; Herling M; Krönke M; Hallek M; Pogge von Strandmann E
Blood; 2013 May; 121(18):3658-65. PubMed ID: 23509156
[TBL] [Abstract][Full Text] [Related]
2. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
[TBL] [Abstract][Full Text] [Related]
3. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Sportoletti P; De Falco F; Del Papa B; Baldoni S; Guarente V; Marra A; Dorillo E; Rompietti C; Adamo FM; Ruggeri L; Di Ianni M; Rosati E
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206399
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome
Wurzer H; Filali L; Hoffmann C; Krecke M; Biolato AM; Mastio J; De Wilde S; François JH; Largeot A; Berchem G; Paggetti J; Moussay E; Thomas C
Front Immunol; 2021; 12():619069. PubMed ID: 34108958
[TBL] [Abstract][Full Text] [Related]
5. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
6. A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells.
Binici J; Hartmann J; Herrmann J; Schreiber C; Beyer S; Güler G; Vogel V; Tumulka F; Abele R; Mäntele W; Koch J
J Biol Chem; 2013 Nov; 288(48):34295-303. PubMed ID: 24133212
[TBL] [Abstract][Full Text] [Related]
7. NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma.
Parry HM; Stevens T; Oldreive C; Zadran B; McSkeane T; Rudzki Z; Paneesha S; Chadwick C; Stankovic T; Pratt G; Zuo J; Moss P
Oncotarget; 2016 Oct; 7(42):68513-68526. PubMed ID: 27655680
[TBL] [Abstract][Full Text] [Related]
8. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
[TBL] [Abstract][Full Text] [Related]
9. PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functions.
Ophir Y; Duev-Cohen A; Yamin R; Tsukerman P; Bauman Y; Gamliel M; Mandelboim O
Oncotarget; 2016 Jul; 7(27):40953-40964. PubMed ID: 27029068
[TBL] [Abstract][Full Text] [Related]
10. Immobilized MHC class I chain-related protein A synergizes with IL-15 and soluble 4-1BB ligand to expand NK cells with high cytotoxicity ex vivo.
Gong W; Xiao W; Qian L; Gong C; Hu M; Pan X; Ji M
Cell Mol Immunol; 2010 Nov; 7(6):477-84. PubMed ID: 20871627
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.
Laprevotte E; Voisin G; Ysebaert L; Klein C; Daugrois C; Laurent G; Fournie JJ; Quillet-Mary A
J Immunol; 2013 Oct; 191(7):3634-40. PubMed ID: 23997218
[TBL] [Abstract][Full Text] [Related]
12. Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.
Sanchez-Correa B; Morgado S; Gayoso I; Bergua JM; Casado JG; Arcos MJ; Bengochea ML; Duran E; Solana R; Tarazona R
Cancer Immunol Immunother; 2011 Aug; 60(8):1195-205. PubMed ID: 21644031
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia.
Hadadi L; Hafezi M; Amirzargar AA; Sharifian RA; Abediankenari S; Asgarian-Omran H
Oncol Res Treat; 2019; 42(4):202-208. PubMed ID: 30870839
[TBL] [Abstract][Full Text] [Related]
14. High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment.
Gonzalez VD; Huang YW; Delgado-Gonzalez A; Chen SY; Donoso K; Sachs K; Gentles AJ; Allard GM; Kolahi KS; Howitt BE; Porpiglia E; Fantl WJ
Cell Rep; 2021 Aug; 36(9):109632. PubMed ID: 34469729
[TBL] [Abstract][Full Text] [Related]
15. Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.
Veuillen C; Aurran-Schleinitz T; Castellano R; Rey J; Mallet F; Orlanducci F; Pouyet L; Just-Landi S; Coso D; Ivanov V; Carcopino X; Bouabdallah R; Collette Y; Fauriat C; Olive D
J Clin Immunol; 2012 Jun; 32(3):632-46. PubMed ID: 22318393
[TBL] [Abstract][Full Text] [Related]
16. Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions.
Wang Z; Guan D; Wang S; Chai LYA; Xu S; Lam KP
Front Immunol; 2020; 11():202. PubMed ID: 32153568
[TBL] [Abstract][Full Text] [Related]
17. Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance.
Calvo T; Reina-Ortiz C; Giraldos D; Gascón M; Woods D; Asenjo J; Marco-Brualla J; Azaceta G; Izquierdo I; Palomera L; Sánchez-Martínez D; Marzo I; Naval J; Vilches C; Villalba M; Anel A
Sci Rep; 2020 Nov; 10(1):19398. PubMed ID: 33173077
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.
Le Garff-Tavernier M; Decocq J; de Romeuf C; Parizot C; Dutertre CA; Chapiro E; Davi F; Debré P; Prost JF; Teillaud JL; Merle-Beral H; Vieillard V
Leukemia; 2011 Jan; 25(1):101-9. PubMed ID: 20975664
[TBL] [Abstract][Full Text] [Related]
19. Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia.
Costello RT; Knoblauch B; Sanchez C; Mercier D; Le Treut T; Sébahoun G
Immunology; 2012 Feb; 135(2):151-7. PubMed ID: 22044312
[TBL] [Abstract][Full Text] [Related]
20. Altered NK cell receptor repertoire and function of natural killer cells in patients with acute myocardial infarction: A three-month follow-up study.
Ortega-Rodríguez AC; Marín-Jáuregui LS; Martínez-Shio E; Hernández Castro B; González-Amaro R; Escobedo-Uribe CD; Monsiváis-Urenda AE
Immunobiology; 2020 May; 225(3):151909. PubMed ID: 32051096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
